Drug intelligence / Profile preview

isopropyl alcohol + allogenic bone-marrow-derived mesenchymal stem cells

Development stage
Unknown
Modality
Stem Cell Therapies → Cell Therapies, Small Molecules
Administration
Topical, Intravenous, Local Injection
01

Overview

This combination drug contains **isopropyl alcohol**, a small molecule antiseptic and disinfectant, and **allogenic bone-marrow-derived mesenchymal stem cells (BM-MSCs)**, which are multipotent stromal cells obtained from the bone marrow of unrelated (non-self) human donors. Isopropyl alcohol acts as a topical agent to rapidly kill bacteria and other microbes by denaturing proteins and disrupting cellular membranes. Allogenic BM-MSCs are used for their anti-inflammatory, immunomodulatory, and tissue-regenerative capabilities—capable of differentiating into various cell types and modulating immune responses in a range of diseases. In clinical practice, allogenic bone marrow MSCs have been approved for the treatment of steroid-refractory acute graft-versus-host disease (e.g., remestemcel-L, brand name Ryoncil) but are also being investigated or used in regenerative medicine settings, including potential applications in neuroprotection and tissue repair. The combination of isopropyl alcohol with allogenic BM-MSCs does not correspond to any widely approved or marketed product. No evidence was found of a drug, approved product, or well-described clinical trial combining both as a therapeutic; as such, this entry is for a hypothetical or research compound consisting of both[1][2][5][6][7].

Other names
isopropanol + allogeneic bone marrow-derived mesenchymal stromal cellsisopropyl alcohol + allogeneic BM-MSCisopropyl alcohol + allogenic BM-MSCisopropyl alcohol + allogenic mesenchymal stem cells

Beyond the preview

Go deeper on isopropyl alcohol + allogenic bone-marrow-derived mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isopropyl alcohol + allogenic bone-marrow-derived mesenchymal stem cells.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call